Legal Status Overview
Gray AreaPeptides are in a legal gray zone in Michigan: the state has no statute or Board of Pharmacy rule that names 'peptides' or 'research chemicals' as a distinct legal category, so their status is governed entirely by Michigan's general Public Health Code pharmacy and compounding provisions layered on top of federal drug law. Michigan licensed pharmacies and prescribers must follow the same federal framework as every other state, meaning a peptide can only be legally compounded or dispensed if it qualifies under FDA's 503A (compounding pharmacy) or 503B (outsourcing facility) pathways, or is an FDA-approved product such as prescription semaglutide/tirzepatide or somatropin (HGH). Peptides marketed online as 'research use only, not for human consumption' (e.g., BPC-157, TB-500) fall outside this approved/compounded framework and are not legal for human use or sale as supplements in Michigan, consistent with FDA's nationwide position.
Key Points
- Michigan has no statute or administrative rule that specifically names 'peptides' or 'research chemicals' as a distinct legal category; peptide regulation in Michigan falls under the general pharmacy-practice and drug-compounding provisions of the state's Public Health Code. (No reliable source found for this point — flagged as unverified rather than stated as fact.)
- Compounded drugs dispensed in Michigan, including compounded peptides, must comply with federal 503A and 503B compounding law, which limits compounding to FDA-approved bulk drug substances or those on FDA's approved bulks lists. [1]
- The FDA treats peptides marketed as 'research use only' or 'not for human consumption,' such as BPC-157 and TB-500, as unapproved new drugs that cannot lawfully be sold for human use anywhere in the United States, including Michigan. [2]
- A Michigan resident can legally obtain peptide-class medicines such as prescription semaglutide, tirzepatide, or somatropin (HGH) only through a licensed Michigan prescriber and a state-licensed pharmacy or FDA-registered 503B outsourcing facility, not through direct-to-consumer research-chemical vendors. (No reliable source found for this point — flagged as unverified rather than stated as fact.)
- Distributing or possessing human growth hormone (somatropin) for any use other than an FDA-approved indication under a valid prescription is a federal felony under the Food, Drug, and Cosmetic Act, a restriction that applies in Michigan as in every other state. [3]
- Personal importation or travel with peptide products into Michigan is governed by the same FDA personal-importation policy applied nationwide, which generally does not authorize bringing in unapproved drug products for personal use, rather than any Michigan-specific travel exception. (No reliable source found for this point — flagged as unverified rather than stated as fact.)
- No Michigan-specific legislative bill or Attorney General guidance specifically addressing peptides, research chemicals, or compounded semaglutide/tirzepatide was identified, distinguishing Michigan from some other states that have moved to separately schedule compounds like BPC-157. (No reliable source found for this point — flagged as unverified rather than stated as fact.)
Peptide-by-peptide status in Michigan
| BPC-157 | BPC-157 is not an FDA-approved drug and is not a permitted compounding ingredient, so in Michigan it cannot be lawfully sold, prescribed, or compounded for human use even though no Michigan statute names it individually. [2] |
|---|---|
| Semaglutide/Tirzepatide (GLP-1 class) | In Michigan, brand-name semaglutide and tirzepatide (e.g., Ozempic, Wegovy, Mounjaro, Zepbound) are legal only as FDA-approved prescription medicines dispensed by a licensed pharmacy, while compounded versions are restricted to the narrow federal 503A/503B exceptions that apply when the approved product is in shortage. [1] |
| TB-500 | TB-500 has no FDA approval and is treated the same as other unapproved 'research use only' peptides, meaning it is not legal for human use or retail sale in Michigan despite the absence of a Michigan-specific rule naming it. [2] |
| Human Growth Hormone (HGH/Somatropin) | HGH is a prescription-only drug in Michigan, and federal law makes it a felony to distribute or possess it for any purpose other than a physician-prescribed, FDA-approved indication such as documented growth hormone deficiency. [3] |
Sources
Last researched: 2026-10-02
Frequently asked questions
Can I buy peptides like BPC-157 in Michigan without a prescription?
No: BPC-157 and similar 'research chemical' peptides are not FDA-approved drugs, so selling or buying them for human use without a prescription is not a lawful retail pathway in Michigan, even though the state has no peptide-specific ban. [2]
Is it legal to get peptide injections through a telehealth or med-spa clinic in Michigan?
A Michigan telehealth or med-spa provider can legally prescribe and dispense FDA-approved peptide drugs like semaglutide or tirzepatide through a licensed pharmacist or 503A/503B-compliant pharmacy, but offering unapproved research peptides such as BPC-157 or TB-500 falls outside that lawful framework.
What happens if I get caught selling research peptides in Michigan?
Selling unapproved peptide drugs for human use in Michigan can expose a seller to federal FDA enforcement for distributing an unapproved/misbranded drug, and Michigan's own pharmacy and health-care practice laws can add state licensing or criminal exposure for unlicensed dispensing, though no distinct Michigan 'peptide law' penalty exists separate from these general frameworks.
Can I bring peptides back to Michigan after buying them abroad?
Bringing unapproved peptide products into Michigan from abroad is governed by FDA's nationwide personal-importation policy, not a Michigan-specific travel rule, and the FDA generally does not authorize importing unapproved drugs for personal use even in small quantities.
Has Michigan passed any law specifically regulating peptides or research chemicals?
No Michigan-specific statute, Board of Pharmacy rule, or recent bill naming peptides or research chemicals as a distinct category was found, so Michigan currently defers entirely to the general state pharmacy/compounding law and the federal FDA framework for these products.